Intravenous Delivery of RNA Encoding Anti-PD-1 Human Monoclonal Antibody for Treating Intestinal Cancer

Recently, antibody-based therapeutic agents are becoming most leading biologics for treating many diseases, especially for cancer. However, large-scale application of antibody drugs is still hampered by high cost and complex technical process. Endogenous expression of proteins or antibodies can be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lipei, Wang, Weiwei, Tian, Jiale, Qi, Chunrun, Cai, Zhengxin, Yan, Wenhui, Xuan, Shihai, Shang, Anquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771528/
https://www.ncbi.nlm.nih.gov/pubmed/35069904
http://dx.doi.org/10.7150/jca.63991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771528/
https://www.ncbi.nlm.nih.gov/pubmed/35069904
http://dx.doi.org/10.7150/jca.63991

Ejemplares similares